NO973531D0 - Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet - Google Patents

Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet

Info

Publication number
NO973531D0
NO973531D0 NO973531A NO973531A NO973531D0 NO 973531 D0 NO973531 D0 NO 973531D0 NO 973531 A NO973531 A NO 973531A NO 973531 A NO973531 A NO 973531A NO 973531 D0 NO973531 D0 NO 973531D0
Authority
NO
Norway
Prior art keywords
melatonin
treatment
patients suffering
drug addiction
addiction
Prior art date
Application number
NO973531A
Other languages
English (en)
Other versions
NO312814B1 (no
NO973531L (no
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of NO973531D0 publication Critical patent/NO973531D0/no
Publication of NO973531L publication Critical patent/NO973531L/no
Publication of NO312814B1 publication Critical patent/NO312814B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19973531A 1995-02-01 1997-07-31 Anvendelse av melatonin ved fremstilling av et medikament for behandling av pasienter som lider av medikamentavhengighet NO312814B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (3)

Publication Number Publication Date
NO973531D0 true NO973531D0 (no) 1997-07-31
NO973531L NO973531L (no) 1997-09-30
NO312814B1 NO312814B1 (no) 2002-07-08

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973531A NO312814B1 (no) 1995-02-01 1997-07-31 Anvendelse av melatonin ved fremstilling av et medikament for behandling av pasienter som lider av medikamentavhengighet

Country Status (22)

Country Link
JP (1) JP4516159B2 (no)
CN (1) CN1083263C (no)
AT (1) AT408188B (no)
AU (1) AU695366B2 (no)
BG (1) BG62876B1 (no)
BR (1) BR9607169A (no)
CZ (1) CZ291349B6 (no)
DK (1) DK176081B1 (no)
EE (1) EE03384B1 (no)
FI (1) FI119586B (no)
IS (1) IS1980B (no)
LU (1) LU90118B1 (no)
LV (1) LV11940B (no)
MD (1) MD1716C2 (no)
NO (1) NO312814B1 (no)
NZ (1) NZ298878A (no)
PL (1) PL183148B1 (no)
SI (1) SI9620022A (no)
SK (1) SK284521B6 (no)
TR (1) TR199700723T1 (no)
TW (1) TW483757B (no)
WO (1) WO1996023496A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1272177T3 (da) 2000-01-05 2007-08-06 Neurim Pharma 1991 Fremgangsmåde og formulering til behandling af resistens over for antihypertensiva og forbundne tilstande
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
EP3620794A1 (en) * 2012-01-26 2020-03-11 Vanda Pharmaceuticals Inc. Determining a circadian rhythm
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
MX2015007909A (es) 2012-12-18 2016-04-25 Vanda Pharmaceuticals Inc Tratamiento de trastornos del ritmo circadiano.
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
ES2828034T3 (es) * 2016-10-31 2021-05-25 Neurim Pharma 1991 Minicomprimidos de melatonina y método de fabricación de los mismos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0518468T3 (da) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatoninholdige sammensætninger
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
BG62876B1 (bg) 2000-10-31
CN1172431A (zh) 1998-02-04
JPH10513177A (ja) 1998-12-15
PL321630A1 (en) 1997-12-08
LV11940B (en) 1998-05-20
SK103097A3 (en) 1998-01-14
AT408188B (de) 2001-09-25
CN1083263C (zh) 2002-04-24
IS4532A (is) 1997-07-25
MD1716B2 (en) 2001-08-31
EE03384B1 (et) 2001-04-16
BR9607169A (pt) 1997-11-11
TR199700723T1 (xx) 1998-02-21
MX9705856A (es) 1998-07-31
FI973185A0 (fi) 1997-07-31
CZ240597A3 (cs) 1998-01-14
SK284521B6 (sk) 2005-05-05
NO312814B1 (no) 2002-07-08
AU695366B2 (en) 1998-08-13
ATA901396A (de) 2001-02-15
WO1996023496A1 (en) 1996-08-08
MD1716C2 (ro) 2002-02-28
JP4516159B2 (ja) 2010-08-04
FI973185A (fi) 1997-09-30
AU4457496A (en) 1996-08-21
IS1980B (is) 2005-01-14
NZ298878A (en) 1999-05-28
DK176081B1 (da) 2006-04-18
NO973531L (no) 1997-09-30
LU90118B1 (fr) 1997-11-13
DK89697A (da) 1997-07-30
PL183148B1 (pl) 2002-05-31
TW483757B (en) 2002-04-21
FI119586B (fi) 2009-01-15
EE9700166A (et) 1998-02-16
BG101803A (en) 1998-04-30
CZ291349B6 (cs) 2003-02-12
MD970254A (en) 1999-05-31
SI9620022A (sl) 1998-10-31
LV11940A (lv) 1998-01-20

Similar Documents

Publication Publication Date Title
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
HK1042825A1 (zh) 治療氣道疾病的化合物和方法以及氣道藥物的給藥方法
HK1001218A1 (en) Use of melatonin for treating patients suffering from drug dependencies
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO973531L (no) Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet
NO20003229D0 (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer
NO975545D0 (no) Cellelinje som produserer analgetiske forbindelser for behandling av smerte
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
IS4528A (is) Bísýklískar afleiður ísóþíóþvagefnis nothæfar viðlæknismeðferð
HUP9903348A3 (en) Transdermal therapeutic system (tts) for administering active substances for the teratment of drug dependency or drug addiction
NO973081D0 (no) Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer
NO995231D0 (no) Terapeutisk behandling av hudlidelser
NO20012106D0 (no) Middel for behandling av benpatobolisme
NO994258L (no) Anvendelse av levobupivakain for behandling av ansiktsmigrene
DK0879054T3 (da) Anvendelse af pyrrolidionderivater til fremstilling af medikamenter til behandling af narkotikamisbrug
NO20014812D0 (no) Fremgangsmåte for tilveiebringelse av kosmetisk/medisinsk terapi
NO981822D0 (no) Anvendelse av proteinet GAX for behandling av cancer
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO974529D0 (no) Innretning for tilförselen av alfuzosin gjennom huden
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
NO982562D0 (no) Sammensetning for behandling av smerte
DE69840432D1 (de) Arzneimittel zur behandlung der augen

Legal Events

Date Code Title Description
MK1K Patent expired